nav-left cat-right
cat-right

BioFocus DPI Extends Drug Discovery Collaboration ...

BioFocus DPI has extended its drug discovery agreement with Eli Lilly and Company until end 2009. Under the terms of the agreement, BioFocus DPI will identify active compounds by screening of Lilly’s library compounds. The agreement extension announced today builds on the successful collaboration begun in March 2005. BioFocus DPI has been working with Lilly on discovering new compounds that target specific cellular...

International Symposium Stem Cell Transplantation ...

The Symposium is focused on the new modality of multiple sclerosis treatment– immunosuppressive therapy followed by autologous stem cell transplantation. Centers in Europe, North and South America, Russia, China, Israel and Australia have successfully performed this procedure, and, to date, more than 600 stem cell transplantations in multiple sclerosis have been performed worldwide. Along with promising results there...
Page 12 of 12« First...89101112